Medicative weight loss

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are a class of medications developed to reduce glucose levels (blood sugars) and support weight loss. They can reduce appetite and affect how your gut (stomach) functions, which helps people feel fuller for longer.

The most commonly used GLP-1 RA for weight loss include:
Mounjaro (Tirzepatide), and Wegovy (Semaglutide)

These medications are administered as a once-weekly injection.

If you are over 18, with a BMI of 30kg/m2 or higher, or those with a BMI of 27kg/m2 or higher who have obesity-related health conditions then this type of medication might be suitable for you.

A specialist from our clinical team will talk through your options which will be based on what you hope to achieve and your medical history. They will advise you if you are suitable for either of the medications.

Mounjaro and Wegovy work through a variety of mechanisms, and while we’re still uncovering the full range of their actions, here’s what we know so far:

• Appetite Reduction
  These medications help reduce appetite, with some patients describing this effect as a decrease in "food noise,” or a quieter, more controlled relationship with food.
• Slower Gastric Emptying
  They slow down the movement of food from the stomach to the intestines, promoting a feeling of fullness and helping to prevent sharp spikes in blood glucose (blood sugar) levels.
• Blood Glucose Regulation
  By balancing hormones that influence blood sugar, these medications help manage blood glucose levels, particularly after consuming carbohydrates.

While many weight loss medications are safe for most people, they can have side effects. It is therefore important to discuss potential risks with our clinical team, especially if you have underlying health conditions.

Weight loss varies by individual and medication. On average, people may lose 15-20% of their body weight when combined with lifestyle changes such as appropriate changes to your nutrition.

Some individuals may need to stay on medication long-term to maintain weight loss, while others may be able to stop after reaching their goals. Our specialist clinical team will work with you to consider how and when to stop taking the medication.

Common side effects include nausea, vomiting, bloating, constipation, and diarrhoea. Some people also report hair loss. In rare cases, serious side effects can exacerbate gallbladder issues, impact on depression, and inflammation of the pancreas.

It’s crucial to inform our specialist clinical team about all medications and supplements you are taking, as there may be interactions.

Yes! Mounjaro and Wegovy have been proven to be a useful intervention for people who have regained weight after bariatric surgery.

GLP-1 medication works best when paired with meaningful lifestyle changes. Tailoring your diet to meet your unique needs and incorporating regular physical activity are essential components. Additionally, your daily habits and routines play a crucial role in your overall success. Setting realistic goals can further enhance and sustain your results. Our specialist clinical team can help you to shape your goals.

Our specialist clinical team can help determine the most suitable treatment for your weight loss based on your medical history, weight loss goals, and any existing health conditions.

If you have any other questions you our specialist practitioners will be happy to help you.